Phosphatases: Their Functions and Druggability in Pathogens

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Molecular Microbiology and Immunology".

Deadline for manuscript submissions: closed (31 January 2022) | Viewed by 6577

Special Issue Editor


E-Mail Website
Guest Editor
Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 – UMR9017 – CIIL - Center for Infection and Immunity of Lille, Lille, France
Interests: tropical diseases; molecular biology; microbiology; infection; cell biology; malaria; drug resistance; parasitology; molecular parasitology; parasitic diseases; Phosphatases; antimalarials

Special Issue Information

Dear Colleagues,

Protein kinases (PKs) and protein phosphatases (PPs) are well-known enzymes for monitoring the phosphorylation status of proteins to deliver appropriate functions. The role of these enzymes is tightly regulated via their own phosphorylation/dephosphorylation state and/or their interactions with diverse partners to fulfill and coordinate specific biological processes at the right time at the right place to maintain cellular homeostasis. Although more attention was focused on kinases to understand their roles in order to develop new means for therapeutic intervention, phosphatases started to emerge in the last years as key players to control different pathways during the cell cycle. Based on recent literature, PPs could not be any more ignored and seem to be involved in diseases and to be feasible drug targets.

In infectious microorganisms, though the functional characterization of phosphatomes is at its infancy, accumulating evidence from yeast and mammalian studies based on biochemical and reverse genetic approaches including multi-omics has shown the essential roles played by PPs. Moreover, some intracellular pathogens, including parasites and viruses manipulate the host phosphatases activities to facilitate their growth and division.

The aim of this Special Issue is to give a platform to researchers to exchange information and updates about PPs in bacteria, fungus, parasites, and agent hijacking host PPs, i.e., viruses to address challenges and future questions.

For this purpose, we cordially invite you to submit research articles, review articles, and short communications related to the various aspects of PPs in pathogens, dealing with molecular and functional characterization of these enzymes (structure, catalytic mechanism, regulation, and signaling pathways), pathogen–host interactions involving host phosphatases and phosphatases as drug targets.

Dr. Jamal Khalife
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (2 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Review

24 pages, 2591 KiB  
Review
Deciphering the Role of Protein Phosphatases in Apicomplexa: The Future of Innovative Therapeutics?
by Aline Fréville, Bénédicte Gnangnon, Asma S. Khelifa, Mathieu Gissot, Jamal Khalife and Christine Pierrot
Microorganisms 2022, 10(3), 585; https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms10030585 - 08 Mar 2022
Cited by 2 | Viewed by 2448
Abstract
Parasites belonging to the Apicomplexa phylum still represent a major public health and world-wide socioeconomic burden that is greatly amplified by the spread of resistances against known therapeutic drugs. Therefore, it is essential to provide the scientific and medical communities with innovative strategies [...] Read more.
Parasites belonging to the Apicomplexa phylum still represent a major public health and world-wide socioeconomic burden that is greatly amplified by the spread of resistances against known therapeutic drugs. Therefore, it is essential to provide the scientific and medical communities with innovative strategies specifically targeting these organisms. In this review, we present an overview of the diversity of the phosphatome as well as the variety of functions that phosphatases display throughout the Apicomplexan parasites’ life cycles. We also discuss how this diversity could be used for the design of innovative and specific new drugs/therapeutic strategies. Full article
(This article belongs to the Special Issue Phosphatases: Their Functions and Druggability in Pathogens)
Show Figures

Figure 1

13 pages, 6957 KiB  
Review
Therapeutic Targeting of Protein Tyrosine Phosphatases from Mycobacterium tuberculosis
by Kasi Viswanatharaju Ruddraraju, Devesh Aggarwal and Zhong-Yin Zhang
Microorganisms 2021, 9(1), 14; https://0-doi-org.brum.beds.ac.uk/10.3390/microorganisms9010014 - 23 Dec 2020
Cited by 16 | Viewed by 3821
Abstract
Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis (Mtb). According to the World Health Organization, an estimated 10 million people developed TB in 2018. The occurrence of drug-resistant TB demands therapeutic agents with novel mechanisms of action. Antivirulence is an [...] Read more.
Tuberculosis (TB) is an airborne infectious disease caused by Mycobacterium tuberculosis (Mtb). According to the World Health Organization, an estimated 10 million people developed TB in 2018. The occurrence of drug-resistant TB demands therapeutic agents with novel mechanisms of action. Antivirulence is an alternative strategy that targets bacterial virulence factors instead of central growth pathways to treat disease. Mycobacterium protein tyrosine phosphatases, mPTPA and mPTPB, are secreted by Mtb into the cytoplasm of macrophages and are required for survival and growth of infection within the host. Here we present recent advances in understanding the roles of mPTPA and mPTPB in the pathogenesis of TB. We also focus on potent, selective, and well-characterized small molecule inhibitors reported in the last decade for mPTPA and mPTPB. Full article
(This article belongs to the Special Issue Phosphatases: Their Functions and Druggability in Pathogens)
Show Figures

Figure 1

Back to TopTop